Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (211-220 of 715) with videos related to

Pageof 72
Sort By:
The Journal of Biological Chemistry|November 10, 1980
Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoproteinH R Lijnen, M Hoylaerts, D Collen
Blood|March 1, 1984
A functional assay of protein C in human plasmaN Sala, W G Owen, D Collen
European Journal of Biochemistry|July 1, 1985
Characterization of the high-affinity interaction between human plasminogen and pro-urokinaseH R Lijnen, C Zamarron, D Collen
The Journal of Laboratory and Clinical Medicine|July 1, 1986
Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivoM Colucci, J A Paramo, D Collen
Blood|May 1, 1986
A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusionP Holvoet, H R Lijnen, D Collen
Circulation Research|May 4, 2002
Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) geneJ Silence, D Collen, H R Lijnen
Thrombosis Research|August 1, 1984
Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitroC Zamarron, H R Lijnen, D Collen
Thrombosis and Haemostasis|August 28, 2001
Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1M Dewerchin, D Collen, H R Lijnen
The Journal of Gene Medicine|March 28, 2001
Gene therapy for hemophiliaM K Chuah, D Collen, T VandenDriessche
Drugs|July 1, 1995
Thrombolytic agents in developmentM Verstraete, H R Lijnen, D Collen
Pageof 72

Showing results (211-220 of 715) with videos related to

Sort By:
Pageof 72
The Journal of Biological Chemistry|November 10, 1980
Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoproteinH R Lijnen, M Hoylaerts, D Collen
Blood|March 1, 1984
A functional assay of protein C in human plasmaN Sala, W G Owen, D Collen
European Journal of Biochemistry|July 1, 1985
Characterization of the high-affinity interaction between human plasminogen and pro-urokinaseH R Lijnen, C Zamarron, D Collen
The Journal of Laboratory and Clinical Medicine|July 1, 1986
Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivoM Colucci, J A Paramo, D Collen
Blood|May 1, 1986
A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusionP Holvoet, H R Lijnen, D Collen
Circulation Research|May 4, 2002
Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) geneJ Silence, D Collen, H R Lijnen
Thrombosis Research|August 1, 1984
Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitroC Zamarron, H R Lijnen, D Collen
Thrombosis and Haemostasis|August 28, 2001
Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1M Dewerchin, D Collen, H R Lijnen
The Journal of Gene Medicine|March 28, 2001
Gene therapy for hemophiliaM K Chuah, D Collen, T VandenDriessche
Drugs|July 1, 1995
Thrombolytic agents in developmentM Verstraete, H R Lijnen, D Collen
Pageof 72